Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.81 is 55% above its 3-year average of 2.46, around the middle of its 3-year range (0.00–8.12).
As of the fiscal period ended Tuesday, June 30, 2026. 3.81% above its 12-month average of 3.67.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.81.
QUICK RATIO (ACID-TEST)
3.81
QUICK RATIO (ACID-TEST) AVG TTM
3.67
QUICK RATIO (ACID-TEST) AVG 3Y
2.66
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.81%
CURRENT VS 3Y AVG
+43.50%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 523 covered companies
CURRENT VS SECTOR MEDIAN
+27.52%
vs the sector median at left
Market Cap
$50.51M
Quick Ratio (Acid-Test)
0.96
TTM Avg
1.17
3Y Avg
2.45
5Y Avg
4.99
Market Cap
$51.71M
Quick Ratio (Acid-Test)
4.04
TTM Avg
3.34
3Y Avg
3.69
5Y Avg
8.08
Market Cap
$51.78M
Quick Ratio (Acid-Test)
1.61
TTM Avg
0.71
3Y Avg
0.60
5Y Avg
0.61
Market Cap
$53.01M
Quick Ratio (Acid-Test)
21.47
TTM Avg
12.14
3Y Avg
11.08
5Y Avg
9.81
Market Cap
$52.80M
Quick Ratio (Acid-Test)
3.89
TTM Avg
3.98
3Y Avg
6.90
5Y Avg
10.09
Market Cap
$55.48M
Quick Ratio (Acid-Test)
3.74
TTM Avg
0.21
3Y Avg
0.34
5Y Avg
1.39
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| eXoZymes, Inc. (EXOZ) | $51.23M | 3.81 | 3.67 | 2.66 | N/A |
| Apollomics, Inc. (APLM)vs › | $50.51M | 0.96 | 1.17 | 2.45 | 4.99 |
| INmune Bio, Inc. (INMB)vs › | $51.71M | 4.04 | 3.34 | 3.69 | 8.08 |
| Envoy Medical, Inc. (COCH)vs › | $51.78M | 1.61 | 0.71 | 0.60 | 0.61 |
| biote Corp. (BTMD)vs › | $50.67M | 0.82 | 0.91 | 2.84 | 2.59 |
| Clene Inc. (CLNN)vs › | $49.84M | 3.07 | 1.20 | 1.50 | 3.41 |
| ImageneBio Inc (IMA)vs › | $53.01M | 21.47 | 12.14 | 11.08 | 9.81 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.80M | 3.89 | 3.98 | 6.90 | 10.09 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $55.48M | 3.74 | 0.21 | 0.34 | 1.39 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $53.99M | 2.37 | 7.60 | 7.51 | 12.19 |
Quick Ratio
3.81
Excludes inventory
Current Ratio
3.81
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.81 |
| 2026-03-31 | 1.32 |
| 2025-12-31 | 2.51 |
| 2025-09-30 | 4.53 |
| 2025-06-30 | 6.19 |
| 2025-03-31 | 6.52 |
| 2024-12-31 | 8.12 |
| 2024-09-30 | 0.25 |
| 2024-06-30 | 0.36 |
| 2024-03-31 | 0.43 |
| 2023-12-31 | 0.50 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 2.32 |
